Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
12/30/2009 | EP2137171A2 Synthesis of chirally purified substituted benzothiazole diamines |
12/30/2009 | EP2137170A1 Desferrithiocin polyether analogues |
12/30/2009 | EP1711481B1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
12/30/2009 | EP1501812B1 Pna monomer and precursor |
12/30/2009 | CN101613325A Process for producing 5-hydroxymethylthiazole |
12/30/2009 | CN100575330C Novel compounds |
12/30/2009 | CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
12/30/2009 | CA2728511A1 Sulfonamide compounds or salts thereof |
12/30/2009 | CA2727340A1 Carboxylic acid compound |
12/30/2009 | CA2727078A1 Sulfoximinamide compounds for combating animal pests |
12/29/2009 | US7638648 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
12/29/2009 | US7638638 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents |
12/29/2009 | US7638637 Orally available sphingosine 1-phosphate receptor agonists and antagonists |
12/29/2009 | US7638540 Benzofuran compound and medicinal composition containing the same |
12/29/2009 | US7638539 5-(4-{2-[5-methyl-2-(4-trifluoromethyl-phenyl)-thiazol -4-yl]-ethoxy}-phenyl)-3H-[1,3,4] oxadiazol-2-one; treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization such as multiple scleroses |
12/29/2009 | US7638536 N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]-3-fluoro-4-hydroxybenzamide; nonpeptide c-mpl ligand; low immunogenicity; proliferate human c-mpl-Ba/F3 cells; increase platelets by promoting the formation of megakaryocytic colonies; orally |
12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
12/29/2009 | CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
12/29/2009 | CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
12/29/2009 | CA2347763C Method of lithiating five-membered heterocycles |
12/24/2009 | US20090318711 Non-Covalent Inhibitors of AmpC ß-Lactamase |
12/24/2009 | US20090318651 Heterocyclic compound and heterocyclic polymers |
12/24/2009 | US20090318513 Compounds exhibiting thrombopoietin receptor agonism |
12/24/2009 | US20090318495 Ethenyl carboxamide derivatives useful as microbiocides |
12/24/2009 | US20090318481 Potentiators Of Glutamate Receptors |
12/24/2009 | US20090318389 Agonists of the sphingosine-1 phosphate receptor |
12/24/2009 | US20090314990 Novel triphenylamine derivatives useful as fluorophores in biology, in particular for two-photon microscopy |
12/23/2009 | WO2009155001A2 Wnt protein signalling inhibitors |
12/23/2009 | WO2009154014A1 External composition |
12/23/2009 | WO2009153238A1 Aminothiazoline compounds for combating insects, arachnids and nematodes |
12/23/2009 | WO2009153226A1 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
12/23/2009 | WO2009153180A1 Heteroaromatic monoamides as orexinin receptor antagonists |
12/23/2009 | WO2009152735A1 Histone deacetylase inhibitors and uses thereof |
12/23/2009 | EP2135864A1 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
12/23/2009 | EP1951695B1 CATALYZED PROCESS OF MAKING C-5-SUBSTITUTED HETEROCYCLIC INHIBITORS OF 11ß-HYDROXY STEROID DEHYDROGENASE TYPE 1 |
12/23/2009 | EP1817309B1 Acetamide compounds as fungicides |
12/23/2009 | EP1709037B1 Hiv protease inhibiting sulfonamides |
12/23/2009 | EP1483251B1 C3-cyano epothilone derivatives |
12/23/2009 | CN100572367C 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes |
12/23/2009 | CA2728139A1 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
12/23/2009 | CA2726703A1 Heteroaromatic monoamides as orexinin receptor antagonists |
12/22/2009 | CA2445749C Dyeing agents for keratin fibers, containing n-heteroarylmethyl-m-phenylenediamine deritaves, as well as new n-heteroarylmethyl-m-phenylenediamine derivatives |
12/22/2009 | CA2290744C Cyclic diamine compounds and medicine containing the same |
12/17/2009 | WO2009152082A1 Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors |
12/17/2009 | WO2009114950A8 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
12/17/2009 | WO2008109727A8 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
12/17/2009 | US20090312556 N-(2-aminiphenyl)-4-(5-((ethylamino)methyl)-1,2-thiazol-2-yl) benzamide and n-(2-aminophenyl)-4-(5-((isopropylamino)methyl)-1,2-thiazol-2-yl) benzamide as hdac inhibitors |
12/17/2009 | US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
12/17/2009 | US20090312376 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
12/17/2009 | US20090312365 Certain Chemical Entities, Compositions, and Methods |
12/17/2009 | US20090312314 Heteroaromatic monoamides as orexinin receptor antagonists |
12/17/2009 | US20090312303 Antidiabetic Bicyclic Compounds |
12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
12/16/2009 | EP2133342A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
12/16/2009 | EP2132189A1 Salts of a selective beta-2 andrenoceptor agonist |
12/16/2009 | EP2132188A2 Substituted phenoxy n-alkylated thiazoledinedione as estrogen related receptor-alpha modulators |
12/16/2009 | CN101605770A Salts 668 |
12/16/2009 | CN101605769A Thiazole compound (as ppard) ligand and pharmaceutical, cosmetic and health food comprised thereof |
12/16/2009 | CN101602745A Synthetic method and application of N, N'-bis-[3-hydroxy-4-(2-benzothiazole)phenyl] carbamide |
12/16/2009 | CN101602744A Preparation method of nitazoxanide |
12/16/2009 | CN101602743A Photochromic thiazole hexatomic ring series-parallel asymmetric perfluoro-cyclopentene compound and preparation method and application thereof |
12/16/2009 | CN100569770C 5-phenylthiazole derivatives and their use as PI3 kinase inhibitors |
12/16/2009 | CN100569760C Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
12/15/2009 | US7632952 Benzothiazoles and the use thereof as medicaments |
12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
12/15/2009 | US7632846 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
12/15/2009 | CA2482917C 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |
12/15/2009 | CA2405621C Cephalosporin intermediates |
12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
12/10/2009 | WO2009148269A2 Benzofluoranthene derivative and an organic luminescent element employing the same |
12/10/2009 | WO2009148163A1 Agent for contracting bladder detrusor muscle and relaxing urethral sphincter muscle |
12/10/2009 | WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
12/10/2009 | WO2009101082A9 Substituted sulfonic acid amide compounds |
12/10/2009 | WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity |
12/10/2009 | US20090306155 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases |
12/10/2009 | US20090306127 Certain Chemical Entities, Compositions and Methods |
12/10/2009 | US20090306112 Antiviral protease inhibitors |
12/10/2009 | US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
12/10/2009 | US20090306073 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers |
12/10/2009 | US20090306069 Azolidinone-vinyl fused-benzene derivatives |
12/10/2009 | US20090306022 7-substituted tetracycline compounds |
12/10/2009 | CA2758016A1 Novel modulators of protein kinase signaling |
12/10/2009 | CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
12/09/2009 | EP2130820A1 Antipruritics |
12/09/2009 | EP2130534A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450 |
12/09/2009 | EP2129668A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
12/09/2009 | EP1300401B1 Thiazole derivatives for use as antiinflammatories |
12/09/2009 | EP1067109B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
12/09/2009 | CN101597268A Processing method of mother liquor of ainothiazoly loximate |
12/09/2009 | CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor |
12/09/2009 | CN100567279C Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
12/09/2009 | CN100567277C Production of N-containing pentabasic heteroaromatic formamidine and salts thereof |
12/09/2009 | CN100567276C Tri(cyclo) substituted amide compounds |
12/09/2009 | CN100567275C 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents |
12/09/2009 | CN100567274C [E]-beta-farnesene analogue, preparing method and application of the same |
12/09/2009 | CN100567269C 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms |
12/09/2009 | CN100567265C Organometallic complexes and organic electroluminescence device using the same |
12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
12/08/2009 | US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |